Pathology of the vulnerable plaque

Renu Virmani1, Allen P Burke, Andrew Farb

  • 1CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA. rvirmani@cvpath.org

Insights

Thin cap fibroatheroma (TCFA) is a precursor lesion for acute coronary syndromes (ACS), often found in proximal arteries. Identifying TCFAs in living patients may help prevent sudden cardiac death.

Area of Science:

  • Cardiovascular Pathology
  • Interventional Cardiology
  • Biomarkers of Atherosclerosis

Background:

  • Acute coronary syndromes (ACS) result from coronary thrombosis, primarily plaque rupture or erosion.
  • Thin cap fibroatheroma (TCFA) is a non-thrombosed lesion resembling acute plaque rupture.
  • Recognizing ACS precursor lesions is crucial for advancing coronary disease treatment.

Purpose of the Study:

  • To characterize the thin cap fibroatheroma (TCFA) as a precursor lesion for acute coronary syndromes (ACS).
  • To identify the prevalence and characteristics of TCFAs in relation to ACS.
  • To explore the potential of TCFA identification in preventing sudden coronary death.

Main Methods:

  • Histopathological analysis of coronary artery lesions in patients with ACS.
  • Morphometric measurements of TCFA components (necrotic core, fibrous cap).
  • Correlation of TCFA presence with clinical risk factors and arterial location.

Main Results:

  • TCFAs, characterized by a thin fibrous cap (<65 microm) and necrotic core, are the primary precursor to plaque rupture in ACS.
  • TCFAs are most prevalent in proximal coronary arteries and associated with positive remodeling, not severe stenosis.
  • TCFAs are linked to high total cholesterol, elevated TC/HDL ratio, postmenopausal women, and high-sensitivity C-reactive protein levels.

Conclusions:

  • Thin cap fibroatheroma (TCFA) is a critical precursor lesion for acute plaque rupture in acute coronary syndromes (ACS).
  • TCFA identification in living patients offers a potential strategy to reduce sudden coronary death.
  • Further research into TCFA detection and management is warranted for ACS prevention.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...